Bio-Rad Laboratories (BIO) Share-based Compensation Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27% |
| Sep 30, 2025 | 6.65% |
| Dec 31, 2024 | 9.96% |
| Sep 30, 2024 | 11.38% |
| Dec 31, 2023 | 13.50% |
| Sep 30, 2023 | 17.50% |
| Dec 31, 2022 | 21.68% |
| Sep 30, 2022 | 21.07% |
| Jun 30, 2022 | 21.30% |
| Mar 31, 2022 | 20.11% |
| Dec 31, 2021 | 22.75% |
| Sep 30, 2021 | 21.68% |
| Jun 30, 2021 | 19.08% |
| Mar 31, 2021 | 20.29% |
| Dec 31, 2020 | 21.26% |
| Sep 30, 2020 | 21.95% |
| Jun 30, 2020 | 15.76% |
| Mar 31, 2020 | 18.96% |
| Dec 31, 2019 | 19.50% |
| Sep 30, 2019 | 22.26% |
| Jun 30, 2019 | 16.21% |
| Mar 31, 2019 | 18.09% |
| Dec 31, 2018 | 17.71% |
| Sep 30, 2018 | 17.93% |
| Jun 30, 2018 | 13.45% |
| Mar 31, 2018 | 11.12% |
| Dec 31, 2017 | 11.42% |
| Sep 30, 2017 | 15.61% |
| Jun 30, 2017 | 10.18% |
| Mar 31, 2017 | 11.48% |
| Dec 31, 2016 | 13.29% |
| Sep 30, 2016 | 14.35% |
| Jun 30, 2016 | 13.56% |
| Mar 31, 2016 | 10.79% |
| Dec 31, 2015 | 10.53% |
| Sep 30, 2015 | 9.59% |
| Jun 30, 2015 | 10.78% |
| Mar 31, 2015 | 12.23% |
| Dec 31, 2014 | 11.49% |
| Sep 30, 2014 | 5.47% |